Artículos de revistas sobre el tema "Remnant cholesterol"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Remnant cholesterol".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Sultan, F., D. Lagrange, X. Le Liepvre y S. Griglio. "Chylomicron-remnant uptake by freshly isolated hepatocytes. Effect of heparin and of hepatic triacylglycerol lipase". Biochemical Journal 258, n.º 2 (1 de marzo de 1989): 587–94. http://dx.doi.org/10.1042/bj2580587.
Texto completoRedgrave, T. G., C. L. Elsegood, J. C. L. Mamo y M. J. Callow. "Effects of hypothyroidism on the metabolism of lipid emulsion models of triacylglycerol-rich lipoproteins in rats". Biochemical Journal 273, n.º 2 (15 de enero de 1991): 375–81. http://dx.doi.org/10.1042/bj2730375.
Texto completoWATTS, G. F., D. C. F. CHAN, P. H. R. BARRETT, I. J. MARTINS y T. G. REDGRAVE. "Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity". Clinical Science 101, n.º 6 (20 de noviembre de 2001): 683–90. http://dx.doi.org/10.1042/cs1010683.
Texto completoChan, Dick C., Gerald F. Watts, P. Hugh Barrett, John CL Mamo y Trevor G. Redgrave. "Markers of Triglyceride-rich Lipoprotein Remnant Metabolism in Visceral Obesity". Clinical Chemistry 48, n.º 2 (1 de febrero de 2002): 278–83. http://dx.doi.org/10.1093/clinchem/48.2.278.
Texto completoMcPherson, Ruth. "Remnant Cholesterol". Journal of the American College of Cardiology 61, n.º 4 (enero de 2013): 437–39. http://dx.doi.org/10.1016/j.jacc.2012.11.009.
Texto completoBowler, A., T. G. Redgrave y J. C. L. Mamo. "Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor". Biochemical Journal 276, n.º 2 (1 de junio de 1991): 381–86. http://dx.doi.org/10.1042/bj2760381.
Texto completoLangsted, Anne, Anne Marie Reimer Jensen, Anette Varbo y Børge G. Nordestgaard. "Low High-Density Lipoprotein Cholesterol to Monitor Long-Term Average Increased Triglycerides". Journal of Clinical Endocrinology & Metabolism 105, n.º 4 (11 de diciembre de 2019): e1657-e1666. http://dx.doi.org/10.1210/clinem/dgz265.
Texto completoLambert, M. S., K. M. Botham y P. A. Mayes. "Variations in composition of dietary fats affect hepatic uptake and metabolism of chylomicron remnants". Biochemical Journal 310, n.º 3 (15 de septiembre de 1995): 845–52. http://dx.doi.org/10.1042/bj3100845.
Texto completoMiyauchi, Kazuhito, Norihiko Kayahara, Masato Ishigami, Hideyuki Kuwata, Hideharu Mori, Hiroyuki Sugiuchi, Tetsumi Irie, Akira Tanaka, Shizuya Yamashita y Taku Yamamura. "Development of a Homogeneous Assay to Measure Remnant Lipoprotein Cholesterol". Clinical Chemistry 53, n.º 12 (1 de diciembre de 2007): 2128–35. http://dx.doi.org/10.1373/clinchem.2007.092296.
Texto completoCHAN, Dick C., Gerald F. WATTS, P. Hugh R. BARRETT, Frans H. O'NEILL, Trevor G. REDGRAVE y Gilbert R. THOMPSON. "Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome". Clinical Science 104, n.º 4 (14 de marzo de 2003): 383–88. http://dx.doi.org/10.1042/cs1040383.
Texto completoBravo, E. y M. Napolitano. "Mechanisms involved in chylomicron remnant lipid uptake by macrophages". Biochemical Society Transactions 35, n.º 3 (22 de mayo de 2007): 459–63. http://dx.doi.org/10.1042/bst0350459.
Texto completoYang, Na, Miao Wang, Jing Liu, Jun Liu, Yongchen Hao y Dong Zhao. "The Level of Remnant Cholesterol and Implications for Lipid-Lowering Strategy in Hospitalized Patients with Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China—Acute Coronary Syndrome Project". Metabolites 12, n.º 10 (24 de septiembre de 2022): 898. http://dx.doi.org/10.3390/metabo12100898.
Texto completoElshazly, Mohamed B., Preethi Mani, Steven Nissen, Danielle M. Brennan, Donald Clark, Seth Martin, Steven R. Jones et al. "Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease". European Journal of Preventive Cardiology 27, n.º 10 (19 de noviembre de 2019): 1091–100. http://dx.doi.org/10.1177/2047487319887578.
Texto completoKaysen, G. A., L. Mehendru, X. M. Pan y I. Staprans. "Both peripheral chylomicron catabolism and hepatic uptake of remnants are defective in nephrosis". American Journal of Physiology-Renal Physiology 263, n.º 2 (1 de agosto de 1992): F335—F341. http://dx.doi.org/10.1152/ajprenal.1992.263.2.f335.
Texto completoLippiello, P. M., P. J. Sisson y M. Waite. "The uptake and metabolism of chylomicron-remnant lipids by rat liver parenchymal and non-parenchymal cells in vitro". Biochemical Journal 232, n.º 2 (1 de diciembre de 1985): 395–401. http://dx.doi.org/10.1042/bj2320395.
Texto completoMorise, Anthony P., Jennifer Tennant, Sari D. Holmes y Danyel H. Tacker. "The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Nonfasting Remnant Cholesterol in a Real World Population". Journal of Lipids 2018 (19 de julio de 2018): 1–8. http://dx.doi.org/10.1155/2018/9194736.
Texto completoJepsen, Anne-Marie K., Anne Langsted, Anette Varbo, Lia E. Bang, Pia R. Kamstrup y Børge G. Nordestgaard. "Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease". Clinical Chemistry 62, n.º 4 (1 de abril de 2016): 593–604. http://dx.doi.org/10.1373/clinchem.2015.253757.
Texto completoVarbo, Anette, Jacob J. Freiberg y Børge G. Nordestgaard. "Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population". Clinical Chemistry 61, n.º 3 (1 de marzo de 2015): 533–43. http://dx.doi.org/10.1373/clinchem.2014.234146.
Texto completoRowsathien, Sathienwit, Krisada Sastravaha, Prajongjit Chamsaard y Prin Vathesatogkit. "Correlation between Levels of Remnant Cholesterol versus LDL, A Cross-Sectional study". International Journal of Scientific Research and Management 10, n.º 12 (17 de diciembre de 2022): 740–63. http://dx.doi.org/10.18535/ijsrm/v10i12.mp02.
Texto completoVarbo, Anette, Jacob J. Freiberg y Børge G. Nordestgaard. "Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study". Clinical Chemistry 64, n.º 1 (1 de enero de 2018): 219–30. http://dx.doi.org/10.1373/clinchem.2017.279463.
Texto completoMansbach, C. M. y R. F. Dowell. "Role of the intestine in chylomicron remnant clearance". American Journal of Physiology-Gastrointestinal and Liver Physiology 269, n.º 1 (1 de julio de 1995): G144—G152. http://dx.doi.org/10.1152/ajpgi.1995.269.1.g144.
Texto completoNAPOLITANO, Mariarosaria, Kelly V. BATT, Michael AVELLA, Elena BRAVO y Kathleen M. BOTHAM. "Lipid synthesis in macrophages derived from the human cell line THP-1: modulation of the effects of native and oxidized chylomicron-remnant-like particles by oestrogen". Clinical Science 101, n.º 4 (14 de septiembre de 2001): 403–13. http://dx.doi.org/10.1042/cs1010403.
Texto completoBaratta, Francesco, Nicholas Cocomello, Mattia Coronati, Domenico Ferro, Daniele Pastori, Francesco Angelico y Maria Del Ben. "Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk". International Journal of Molecular Sciences 24, n.º 5 (21 de febrero de 2023): 4268. http://dx.doi.org/10.3390/ijms24054268.
Texto completoNnamdi, Chinonso, Amah Ubuo, Anaelechi Onuegbu, Madu Olisekodiaka, Chima Okpara, Ekenedirichukwu Okwara, Adamma Analike y Chidiadi Njoku. "Remnant Cholesterol and Leptin: Any Association in Normal Weight, Over Weight and Obese Individuals in South East Nigeria". ULUTAS MEDICAL JOURNAL 8, n.º 4 (2022): 135. http://dx.doi.org/10.5455/umj.20220616022839.
Texto completoTwickler, T. B., G. M. Dallinga-Thie, J. S. Cohn y M. J. Chapman. "Elevated Remnant-Like Particle Cholesterol Concentration". Circulation 109, n.º 16 (27 de abril de 2004): 1918–25. http://dx.doi.org/10.1161/01.cir.0000125278.58527.f3.
Texto completoVarbo, Anette y Børge G. Nordestgaard. "Remnant cholesterol and ischemic heart disease". Current Opinion in Lipidology 25, n.º 4 (agosto de 2014): 266–73. http://dx.doi.org/10.1097/mol.0000000000000093.
Texto completoMearns, Bryony M. "Role of remnant cholesterol in IHD". Nature Reviews Cardiology 10, n.º 10 (27 de agosto de 2013): 553. http://dx.doi.org/10.1038/nrcardio.2013.132.
Texto completoÖörni, Katariina, Satu Lehti, Peter Sjövall y Petri T. Kovanen. "Triglyceride-Rich Lipoproteins as a Source of Proinflammatory Lipids in the Arterial Wall". Current Medicinal Chemistry 26, n.º 9 (21 de mayo de 2019): 1701–10. http://dx.doi.org/10.2174/0929867325666180530094819.
Texto completoKuznetsova, A. S. "Interrelationship of dyslipidemia with indicators of regional hemodynamics in patients with atherosclerosis of the visceral branches of the abdominal aorta". Regional blood circulation and microcirculation 15, n.º 3 (30 de septiembre de 2016): 44–49. http://dx.doi.org/10.24884/1682-6655-2016-15-3-44-49.
Texto completoLangsted, A., C. M. Madsen y B. G. Nordestgaard. "Contribution of remnant cholesterol to cardiovascular risk". Journal of Internal Medicine 288, n.º 1 (7 de abril de 2020): 116–27. http://dx.doi.org/10.1111/joim.13059.
Texto completoBurnett, John R., Amanda J. Hooper y Robert A. Hegele. "Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk". Journal of the American College of Cardiology 76, n.º 23 (diciembre de 2020): 2736–39. http://dx.doi.org/10.1016/j.jacc.2020.10.029.
Texto completoCastañer, Olga, Xavier Pintó, Isaac Subirana, Antonio J. Amor, Emilio Ros, Álvaro Hernáez, Miguel Ángel Martínez-González et al. "Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease". Journal of the American College of Cardiology 76, n.º 23 (diciembre de 2020): 2712–24. http://dx.doi.org/10.1016/j.jacc.2020.10.008.
Texto completoChinonso, Nnamdi J., Ubuo K. Amah, Onuegbu J. Anaelechi, Okeke C. Stellarmaris, Oti D. Chukwudi, Iwuagwu G. Obioma, Ikechukwu S. Nwaisaac y Ahams E. Chika. "Comparative Study of Remnant Cholesterol, Some Lipid Fractions and FBS Level in Overweight and Obese Participants in South East Nigeria". Asian Journal of Research in Biochemistry 12, n.º 3 (5 de mayo de 2023): 11–19. http://dx.doi.org/10.9734/ajrb/2023/v12i3235.
Texto completoPackard, Chris J. "Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease". Current Atherosclerosis Reports 24, n.º 3 (17 de febrero de 2022): 133–42. http://dx.doi.org/10.1007/s11883-022-00994-z.
Texto completoCarrella, Massimino, Annalisa Csillaghy, Renato de Mercato y Agesilao D'Arienzo. "Biliary Excretion of Chylomicron Remnant Cholesterol in the Rat: Responses to the Expansion of Their Plasma Pool and Promoting Role of Stimulated Bile-Acid Synthesis". Clinical Science 89, n.º 2 (1 de agosto de 1995): 121–28. http://dx.doi.org/10.1042/cs0890121.
Texto completoWieczorek, Ewa, Agnieszka Ćwiklińska, Agnieszka Kuchta, Barbara Kortas-Stempak, Anna Gliwińska y Maciej Jankowski. "The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism". Biomedicines 9, n.º 12 (5 de diciembre de 2021): 1839. http://dx.doi.org/10.3390/biomedicines9121839.
Texto completoWilson, Peter W. F. y Alan T. Remaley. "Ischemic Heart Disease Risk and Remnant Cholesterol Levels". Journal of the American College of Cardiology 79, n.º 24 (junio de 2022): 2398–400. http://dx.doi.org/10.1016/j.jacc.2022.04.016.
Texto completoToth, Peter P., Harold Bays, William Brown, Joanne Tomassini, Colin Wang, Adam Polis y Andrew Tershakovec. "CHOLESTEROL IN REMNANT-LIPOPROTEINS AS MEASURED BY DIFFERENT". Journal of the American College of Cardiology 65, n.º 10 (marzo de 2015): A1569. http://dx.doi.org/10.1016/s0735-1097(15)61569-8.
Texto completoCully, Megan. "Remnant cholesterol is associated with ischaemic heart disease". Nature Reviews Cardiology 10, n.º 3 (22 de enero de 2013): 119. http://dx.doi.org/10.1038/nrcardio.2013.3.
Texto completoKaltoft, Morten, Anne Langsted y Børge G. Nordestgaard. "Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study". European Heart Journal 41, n.º 24 (8 de abril de 2020): 2288–99. http://dx.doi.org/10.1093/eurheartj/ehaa172.
Texto completoHirao, Yuhko, Katsuyuki Nakajima, Tetsuo Machida, Masami Murakami y Yasuki Ito. "Development of a Novel Homogeneous Assay for Remnant Lipoprotein Particle Cholesterol". Journal of Applied Laboratory Medicine 3, n.º 1 (1 de julio de 2018): 26–36. http://dx.doi.org/10.1373/jalm.2017.024919.
Texto completoLeary, Elizabeth Teng, Tao Wang, Daniel J. Baker, Donald D. Cilla, Jianhua Zhong, G. Russell Warnick, Katsuyuki Nakajima y Richard J. Havel. "Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma". Clinical Chemistry 44, n.º 12 (1 de diciembre de 1998): 2490–98. http://dx.doi.org/10.1093/clinchem/44.12.2490.
Texto completoYU, Kenneth C. W. y John C. L. MAMO. "Chylomicron-remnant-induced foam cell formation and cytotoxicity: a possible mechanism of cell death in atherosclerosis". Clinical Science 98, n.º 2 (11 de enero de 2000): 183–92. http://dx.doi.org/10.1042/cs0980183.
Texto completo杜, 柯锐. "Remnant Cholesterol and Status of Dyslipidemia in Hemodialysis Patients". Advances in Clinical Medicine 12, n.º 07 (2022): 6106–12. http://dx.doi.org/10.12677/acm.2022.127880.
Texto completoNordestgaard, Børge G. "A New Start for Triglycerides and Remnant Cholesterol—Nonfasting". Clinical Chemistry 63, n.º 8 (1 de agosto de 2017): 1418–19. http://dx.doi.org/10.1373/clinchem.2016.268938.
Texto completoPirillo, Angela, Giuseppe D. Norata y Alberico L. Catapano. "Beyond LDL-C levels, does remnant cholesterol estimation matter?" European Journal of Preventive Cardiology 27, n.º 10 (3 de febrero de 2020): 1088–90. http://dx.doi.org/10.1177/2047487319899622.
Texto completoOhnishi, Hirofumi, Sigeyuki Saitoh, Satoru Takagi, Jun-ichi Ohata, Takeshi Isobe, Yuka Kikuchi, Hiroshi Takeuchi y Kazuaki Shimamoto. "Relationship between insulin-resistance and remnant-like particle cholesterol". Atherosclerosis 164, n.º 1 (septiembre de 2002): 167–70. http://dx.doi.org/10.1016/s0021-9150(02)00057-6.
Texto completoToth, Peter P., W. Virgil Brown, Harold E. Bays, Joanne E. Tomassini, Colin Wang, Adam B. Polis y Andrew M. Tershakovec. "Cholesterol in Remnant-Lipoproteins as Measured by Different Methods". Journal of Clinical Lipidology 9, n.º 3 (mayo de 2015): 414–15. http://dx.doi.org/10.1016/j.jacl.2015.03.017.
Texto completoSchwartz, Gregory G., Markus Abt, Michael Miller, Hardi Mundl y Anders Olsson. "REMNANT CHOLESTEROL AND RESIDUAL RISK AFTER ACUTE CORONARY SYNDROME". Journal of the American College of Cardiology 63, n.º 12 (abril de 2014): A257. http://dx.doi.org/10.1016/s0735-1097(14)60257-6.
Texto completoToth, P. P., H. E. Bays, W. V. Brown, J. E. Tomassini, Y. Wang, A. B. Polis y A. M. Tershakovec. "Cholesterol in remnant-lipoproteins as measured by different methods". Atherosclerosis 241, n.º 1 (julio de 2015): e39. http://dx.doi.org/10.1016/j.atherosclerosis.2015.04.142.
Texto completo